Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1974 1
1978 1
1980 1
1985 1
1989 1
1990 1
1992 1
1997 2
1998 1
1999 1
2000 2
2001 2
2002 3
2003 1
2004 2
2007 2
2008 1
2011 1
2012 2
2013 4
2014 11
2015 9
2016 2
2017 3
2018 14
2019 8
2020 8
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Among authors: steffens cc. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Tools for detecting insect semiochemicals: a review.
Brezolin AN, Martinazzo J, Muenchen DK, de Cezaro AM, Rigo AA, Steffens C, Steffens J, Blassioli-Moraes MC, Borges M. Brezolin AN, et al. Among authors: steffens c. Anal Bioanal Chem. 2018 Jul;410(17):4091-4108. doi: 10.1007/s00216-018-1118-3. Epub 2018 Jun 11. Anal Bioanal Chem. 2018. PMID: 29926152 Review.
Heavy metals detection in river water with cantilever nanobiosensor.
Rigo AA, Cezaro AM, Muenchen DK, Martinazzo J, Manzoli A, Steffens J, Steffens C. Rigo AA, et al. Among authors: steffens c. J Environ Sci Health B. 2020;55(3):239-249. doi: 10.1080/03601234.2019.1685318. Epub 2019 Nov 4. J Environ Sci Health B. 2020. PMID: 31680618
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Hegewisch-Becker S, Graeven U, Lerchenmüller CA, Killing B, Depenbusch R, Steffens CC, Al-Batran SE, Lange T, Dietrich G, Stoehlmacher J, Tannapfel A, Reinacher-Schick A, Quidde J, Trarbach T, Hinke A, Schmoll HJ, Arnold D. Hegewisch-Becker S, et al. Among authors: steffens cc. Lancet Oncol. 2015 Oct;16(13):1355-69. doi: 10.1016/S1470-2045(15)00042-X. Epub 2015 Sep 8. Lancet Oncol. 2015. PMID: 26361971 Clinical Trial.
81 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page